Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.170 -0.580 (-5.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

65 66 Next >

What's Next For Novavax Stock As COVID Vaccine Clears Key Hurdle In US ↗

June 08, 2022

After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 08, 2022

Good morning, investors! Another busy day of trading awaits and with that comes our biggest pre-market stock movers for Wednesday!

Via InvestorPlace

20 Stocks Moving in Wednesday's Pre-Market Session ↗

June 08, 2022

Gainers Cyren Ltd. (NASDAQ: CYRN) rose 31.1% to $2.32 in pre-market trading after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure...

Via Benzinga

A Peek Into The Markets: US Stock Futures Down Ahead Of Wholesale Inventories Data ↗

June 08, 2022

Pre-open movers

Via Benzinga

5 Stocks To Watch For June 8, 2022 ↗

June 08, 2022

Some of the stocks that may grab investor focus today are:

Via Benzinga

Novavax's COVID-19 Vaccine For Adults Over 18 Backed By FDA Advisors: What's Next? ↗

June 07, 2022

Novavax, Inc. (NASDAQ: NVAX) announced the U.S.

Via Benzinga

Novavax Shares Gain Following FDA Advisory Committee's Positive Vote On Emergency Use Authorization (EUA) For COVID-19 Vaccine ↗

June 07, 2022

Novavax’s (NASDAQ: NVAX) COVID-19 vaccine (NVX-CoV2373) receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee (VRBPAC), recommending...

Via Benzinga

What's Going On With Novavax Stock Today? ↗

June 07, 2022

Novavax Inc (NASDAQ: NVAX) shares have been halted since the pre-market session as the U.S. Food and Drug Administration holds a meeting to determine the fate of the company's COVID-19 vaccine.

Via Benzinga

Novavax Stock Halted As FDA Mulls Its Rival To Covid Shots From Pfizer, Moderna ↗

June 07, 2022

An FDA committee will vote on whether to recommend the shot based on its merits.

Via Investor's Business Daily

Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted on Tuesday ↗

June 07, 2022

We've seen a large array of halted stocks today as circuit breakers take effect to reign in unexpected volatility for some shares.

Via InvestorPlace

Why Is Kiromic BioPharma (KRBP) Stock Up 75% Today? ↗

June 07, 2022

Kiromic BioPharma (KRBP) stock is rocketing higher on Tuesday following announcing a new sponsored research agreement (SRA).

Via InvestorPlace

SJM Stock in Focus as J.M. Smucker Anticipates $125 Million Hit From Peanut Butter Recalls ↗

June 07, 2022

J.M. Smucker (SJM) stock is on the move today after the company revealed the expected impact of its recent peanut butter recalls.

Via InvestorPlace

NVAX Stock Alert: 14 Things to Know as the Novavax Vaccine Faces the FDA Today ↗

June 07, 2022

Novavax (NVAX) stock is in the news today as investors prepare for the results from the vaccine company's meeting with the FDA.

Via InvestorPlace

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study ↗

June 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Premarket Brief On Trending Tickers: Amazon, Alibaba, DiDi, Solaredge, And More ↗

June 06, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

Via Benzinga

69 Biggest Movers From Friday ↗

June 06, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...

Via Benzinga

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗

June 05, 2022

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.

Via Benzinga

6 Biotech Stocks to Buy Now Ahead of These June Catalysts ↗

June 03, 2022

These biotech stocks face some key make-or-break events in June that could have big implication for their futures.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 03, 2022

Via Benzinga

Mullen (MULN) Stock Shakes Off EV Woes on CEO Interview ↗

June 03, 2022

Mullen (MULN) stock is bucking the trend of other electric vehicle (EV) companies today with its shares rising higher on an interview.

Via InvestorPlace

Why Is Lucid Motors (LCID) Stock Down Today? ↗

June 03, 2022

Lucid Motors (LCID) stock is slipping on Friday but not due to any news directly from the electric vehicle (EV) company.

Via InvestorPlace

Novavax (NVAX) Stock Falls 25% on FDA Heart Inflammation Warning ↗

June 03, 2022

Novavax (NVAX) stock is falling on Friday after the FDA requested a heart inflammation warning for the company's Covid-19 vaccine.

Via InvestorPlace

Novavax Crashes After FDA Suggests Its Covid Vaccine Causes Heart Inflammation ↗

June 03, 2022

Six recipients of the Covid vaccine experienced myocarditis or pericarditis.

Via Investor's Business Daily

40 Stocks Moving In Friday's Mid-Day Session ↗

June 03, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May ↗

June 03, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday.

Via Benzinga

Jim Cramer Shares His Opinion On Roblox, Century Aluminum And More ↗

June 01, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Roblox Corp (NASDAQ: RBLX) as it is not making money.

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates ↗

May 31, 2022

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,...

Via Benzinga

Let the Market’s Shakeout Finish Before Buying Novavax Stock ↗

May 26, 2022

Even after the company's first profitable quarter, it's still too early to accumulate NVAX stock as an analyst issues a bearish price target.

Via InvestorPlace

$100 Invested In Novavax 5 Years Ago Would Be Worth This Much ↗

May 24, 2022

Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 9.78% on an annualized basis producing an average annual return of 19.75%. Currently, Novavax has a market capitalization of...

Via Benzinga

70 Biggest Movers From Friday ↗

May 31, 2022

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for...

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novavax, Inc. - Common Stock (NQ:NVAX)

All News about Novavax, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today